When clinical lab Aeon Global Health entered the hereditary testing market, they knew that automation was critical to success. Genomics software was faster than human experts—and more cost-effective.
Listen to our round-table discussion to discover how Aeon selected a genomics solution. Gain valuable insights to build on Aeon’s experience and accelerate your own path to success.
- Shawn Desai, Ph.D., J.D., CTO, Aeon Global Health
- Ramon Felciano, Ph.D., CTO and VP Strategy, QIAGEN Bioinformatics
- Kristina Kermanshahche, Global Director Life Sciences, Intel Corporation
Watch Now – to learn how to put precision medicine on the fast track.